文献速递心外重症与机械循环支持

主动脉内球囊反搏联合VA-ECMO对心源性休克患者死亡率的影响:系统评价与荟萃分析

Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该系统评价与荟萃分析旨在比较VA-ECMO联合IABP与单用VA-ECMO对成人心源性休克患者的疗效。共纳入29项研究、4576例患者,主要终点为院内死亡。结果显示联合IABP与院内死亡降低相关(RR 0.90;95%CI 0.85-0.95;P<0.0001),且神经、胃肠及肢体相关并发症无显著差异。

要点

  • VA-ECMO联合IABP与心源性休克患者院内死亡降低相关(RR 0.90)。
  • 在ECPR、心脏术后心源性休克及缺血性心脏病亚组中,联合IABP均与死亡降低相关。
  • 联合IABP未显著增加神经、胃肠及肢体相关并发症。

核心结论

  • VA-ECMO联合IABP与心源性休克患者院内死亡降低相关。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Embase、Cochrane Library及国际临床试验注册平台。
  • 纳入29项研究,共4576例成人心源性休克患者,比较VA-ECMO联合IABP与单用VA-ECMO。
  • 主要终点为院内死亡,次要终点包括神经、胃肠及肢体相关并发症;方案注册于PROSPERO(CRD42017069259)。

主要发现

  • 单用VA-ECMO组院内死亡1441/2285(63.1%),联合IABP组为1339/2291(58.4%)。
  • 联合IABP与院内死亡降低相关(RR 0.90;95%CI 0.85-0.95;P<0.0001)。
  • 体外心肺复苏患者联合IABP的院内死亡RR为0.78(95%CI 0.64-0.95;P=0.01)。
  • 心脏术后心源性休克患者联合IABP的院内死亡RR为0.91(95%CI 0.85-0.98;P=0.008)。
  • 缺血性心脏病患者联合IABP的院内死亡RR为0.83(95%CI 0.73-0.96;P=0.009)。

临床怎么用

  • 对于心源性休克患者,在VA-ECMO基础上联合IABP可能降低院内死亡风险。
  • 在体外心肺复苏、心脏术后心源性休克及缺血性心脏病患者中,可考虑联合使用IABP。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An intra-aortic balloon pump (IABP) concomitant with venoarterial extracorporeal membrane oxygenation (VA-ECMO) is frequently used to support patients with refractory cardiogenic shock (CS). Because of the lack of evidence of the adjunctive benefit, the goal of the study was to compare the effect of VA-ECMO plus IABP with that of VA-ECMO alone. Systematic searches were conducted to identify studies using PubMed, Embase, the Cochrane Library and the International Clinical Trials Registry Platform. Studies reporting on patients with adult CS treated with VA-ECMO plus IABP or VA-ECMO alone were identified and included. The primary outcome was in-hospital death. The secondary outcomes included neurological, gastrointestinal and limb-related complications. The study protocol was registered at PROSPERO (CRD42017069259). A total of 29 studies comprising 4576 patients were included. The pooled in-hospital deaths of patients on VA-ECMO were 1441/2285 (63.1%) compared with 1339/2291 (58.4%) for patients with adjunctive IABP. VA-ECMO plus IABP was associated with decreased in-hospital deaths [risk ratio (RR) 0.90; 95% confidence interval (CI) 0.85-0.95; P < 0.0001]. Moreover, IABP was related to decreased in-hospital deaths of patients with extracorporeal cardiopulmonary resuscitation, postcardiotomy CS and ischaemic heart disease (RR 0.78; 95% CI 0.64-0.95; P = 0.01; RR 0.91; 95% CI: 0.85-0.98; P = 0.008; RR 0.83; 95% CI 0.73-0.96, P = 0.009). Neurological, gastrointestinal and limb-related complications did not differ significantly between patients on ECMO with and without concurrent IABP. VA-ECMO plus IABP was associated with decreased in-hospital deaths in patients with CS.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Li Y, Yan S, Gao S, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis†. Eur J Cardiothorac Surg. 2019. PMID: 30252028. doi:10.1093/ejcts/ezy304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。